Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Vistagen Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +5 vs. Q2 2024
- Shares held
- 15.3M
- −674.7K (−4.2%) vs. Q2 2024
- Total value
- $45.3M
- −$9.60M (−17.5%) vs. Q2 2024
- New holders
- 8
- 9 more added
- Sold out
- 3
- 13 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 2,676,580 | $8.06M | 0.68% | 00.0% | Unchanged |
| BVF Inc | 2,000,000 | $6.02M | 0.18% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,793,166 | $5.40M | 0.00% | 00.0% | Unchanged |
| StemPoint Capital LP | 1,846,792 | $4.90M | 1.47% | −1,790−0.1% | Reduced |
| Commodore Capital LP | 1,575,000 | $4.74M | 0.30% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,517,696 | $4.57M | 0.38% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 808,550 | $2.43M | 0.40% | 00.0% | Unchanged |
| Great Point Partners LLC | 674,075 | $2.03M | 0.61% | −855,263−55.9% | Reduced |
| BlackRock, Inc. | 412,129 | $1.24M | 0.00% | +412,129 | New |
| Citadel Advisors LLC | 321,885 | $968.9K | 0.00% | −307,760−48.9% | Reduced |
| Geode Capital Management, LLC | 258,524 | $778.4K | 0.00% | −31,570−10.9% | Reduced |
| Renaissance Technologies LLC | 190,600 | $573.7K | 0.00% | +125,700+193.7% | Added |
| Goldman Sachs Group Inc | 176,261 | $530.5K | 0.00% | +1,279+0.7% | Added |
| ADAR1 Capital Management, LLC | 163,078 | $490.9K | 0.08% | +163,078 | New |
| BML Capital Management, LLC | 150,000 | $451.5K | 0.27% | 00.0% | Unchanged |
| State Street Corp | 88,708 | $267.0K | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 88,466 | $266.3K | 0.00% | 00.0% | Unchanged |
| AdvisorShares Investments LLC | 67,780 | $204.0K | 0.04% | +16,000+30.9% | Added |
| Two Sigma Investments, LP | 61,542 | $185.2K | 0.00% | −5,969−8.8% | Reduced |
| Susquehanna International Group, LLP | 52,094 | $156.8K | 0.00% | −13,013−20.0% | Reduced |
| Northern Trust Corp | 49,431 | $148.8K | 0.00% | −531−1.1% | Reduced |
| Valence8 US LP | 34,376 | $103.5K | 0.05% | +34,376 | New |
| American Century Companies Inc | 30,197 | $90.9K | 0.00% | −118−0.4% | Reduced |
| Squarepoint Ops LLC | 27,575 | $83.0K | 0.00% | +16,180+142.0% | Added |
| Millennium Management LLC | 25,337 | $76.3K | 0.00% | +25,337 | New |
| Charles Schwab Investment Management Inc | 23,302 | $70.1K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 23,000 | $69.0K | 0.00% | +5,893+34.4% | Added |
| HighTower Advisors, LLC | 20,828 | $64.0K | 0.00% | +20,828 | New |
| Virtu Financial LLC | 20,210 | $61.0K | 0.00% | +4,722+30.5% | Added |
| Kestra Advisory Services, LLC | 20,033 | $60.3K | 0.00% | +20,033 | New |
| Jane Street Group, LLC | 19,659 | $59.2K | 0.00% | +19,659 | New |
| Advisor Group Holdings, Inc. | 10,226 | $30.8K | 0.00% | −800−7.3% | Reduced |
| UBS Group AG | 10,121 | $30.5K | 0.00% | −9,145−47.5% | Reduced |
| Morgan Stanley | 5,319 | $16.0K | 0.00% | −547−9.3% | Reduced |
| Royal Bank of Canada | 4,501 | $14.0K | 0.00% | +3,420+316.4% | Added |
| Caption Management, LLC | 4,460 | $13.4K | 0.00% | +4,460 | New |
| CWM, LLC | 2,416 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,259 | $6.80K | 0.00% | −225−9.1% | Reduced |
| Bank of America Corp | 1,810 | $5.45K | 0.00% | +1,572+660.5% | Added |
| Citigroup Inc | 1,229 | $3.70K | 0.00% | +1,226+40,866.7% | Added |
| BFSG, LLC | 1,000 | $3.01K | 0.00% | 00.0% | Unchanged |
| SJS Investment Consulting Inc. | 100 | $301 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 80 | $246 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 81 | $244 | 0.00% | 00.0% | Unchanged |
| Fairman Group, LLC | 29 | $87 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 25 | $75 | 0.00% | −4,121−99.4% | Reduced |
| JPMorgan Chase & Co | 16 | $48 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −19,261−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −492−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |